Navigation Links
Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections
Date:7/13/2010

l Assistant™ in 2008 to electronically record requests to remove urinary and central line catheters, and to document catheter-related urinary tract and bloodstream infections. Intervention requests were made by the hospital's infection preventionist, who attended daily rounds with the medical teams and often suggested the removal of urinary and central line catheters to help reduce infection risk. Months with more interventions were associated with fewer catheter-related infections, providing data to support infection-prevention efforts.

Catheter-associated infections are a significant problem for hospitals. Urinary tract infections (UTIs) account for 40 percent of the healthcare-acquired infections (HAIs) in the United States,(1) and 250,000 to 500,000 catheter-associated bloodstream infections (CABIs) occur in the nation each year. In addition to improving patient safety, avoiding these infections can result in significant cost savings for hospitals -- costs for each UTI and CABI are estimated at $600 and up to $29,000, respectively.(2)

According to Alex Chavez, C.I.C., infection-control practitioner at Memorial Hospital Miramar, preventing catheter-related infections is a focus for infection preventionists, but manually documenting and assessing the impact of interventions on infection rates can be challenging. When Chavez learned that the hospital was using TheraDoc to assess pharmacy interventions, he realized that the technology could do the same for infection prevention.

"The ability to electronically document interventions and then tie them to reduced infection rates is critical," Chavez said. "TheraDoc helps us quantify the value of infection preventionists in improving patient care and demonstrates the importance of interactions
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Hospira Announces Intention to Complete Tender Offer for Shares of Javelin Pharmaceuticals
2. Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)
3. Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
4. Hospira to Standardize Intravenous (I.V.) Administration Sets Portfolio to Non-DEHP
5. Hospira Highlights a Year of Significant Progress at Its 2010 Annual Meeting of Shareholders
6. Hospira to Present at Citi 2010 Global Health Care Conference May 27, 2010
7. Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash Grants
8. Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010
9. Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
10. Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers
11. Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015  BioLife Solutions, Inc. (NASDAQ: BLFS ), a ... hypothermic storage and cryopreservation freeze media and ... ("BioLife" or the "Company"), announced that the Company is scheduled ... The Company is scheduled to present at the Conference ... the Grand Hyatt Hotel in New York City ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... protection, repair and regeneration, today announced that J.J. ... to present a corporate overview at two upcoming investor ... the SeeThruEquity 4 th Annual Microcap Conference on ... City at 11:00 am EDT.  A webcast ...
(Date:5/22/2015)... , May 22, 2015 According ... Market by Product (Consumables, Instruments, Services), by Test Type ... Chromatography, Flow Cytometry), by End Users - Global Forecast ... Market is expected to reach $736.85 Million by 2020 ... of 10.25%. Browse 71 market data ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4
... BOULDER, Colo. and MONTREAL, Feb. 14 Pharmion,Corporation ... MYG) today announced,that the U.S. Food and Drug ... inhibitor, MGCD0103, as an Orphan,Drug for the treatment ... Criteria for designation require that the product be ...
... Australia, Feb. 13 Progen,Pharmaceuticals Limited (ASX: ... results from a phase 2 investigator-initiated trial ... Taxotere(R),(docetaxel) administered to patients with prostate cancer. ... Haematology and Oncology Clinics, the,principal investigator conducting ...
Cached Medicine Technology:Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 2Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 3Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 4Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium 2Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium 3
(Date:5/22/2015)... 2015 Power Systems is proud to announce ... race season. Drobeck is in his second year of racing ... with the Missoula Fire Department in Missoula, MT. He entered ... 2014. During his career, he has had 15 1st Place ... top 10 finishes in all seven of his 2014 races, ...
(Date:5/22/2015)... PA (PRWEB) May 22, 2015 According to ... a hub for drug related death, totaling almost 2,500 confirmed ... as reported by state officials, totals 2,489 deaths stemming from ... work out, Pennsylvania loses seven people every day to fatal ... has been singled out as one of the most rife ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Medivo, Inc., a ... “Positivity Rates and Genotype Results in ‘Baby Boomers’ Screened for ... a Nationwide Lab Test Database” at Digestive Disease Week, May ... Clinical Affairs and Analytics team members Carol Smyth, MB; Jason ... Andrea Parker, MSI, along with Nancy Reau, MD from the ...
(Date:5/22/2015)... 22, 2015 Wimbledon Health Partners, the ... (EKG), echocardiogram and NCV testing , is proud ... respected All American National athlete, to the Wimbledon Athletics ... the high level of testing and information it provides ... their athletic trainers, this way they can focus on ...
(Date:5/22/2015)... Phoenix, AZ (PRWEB) May 22, 2015 ... Special Olympics, Parker and Sons is offering to donate ... for installing an AC unit or water softening system. ... their behalf; Parker and Sons gets business; and the ... , The Special Olympics helps over 4.4 million ...
Breaking Medicine News(10 mins):Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
... 2 Mylan Inc. (NYSE: MYL ),today announced ... Asia Pacific following the completion of Mylan,s acquisition of,Merck,s ... over 30 years in the pharmaceuticals,industry and has extensive ... UK, U.S. and Asia Pacific regions. At Merck,Generics, he ...
... Mylan Inc. (NYSE: MYL ),today announced the ... (Europe, Middle East and Africa) following the completion,of Mylan,s ... Generics, M. Barret most recently served as Region Director,EMEA, ... position in 2004,following his role as Area Director for ...
... in obstetrics and ... emergency departments., CHICAGO, Oct. 2 ... according to the Aon Corporation 2007,Hospital Professional Liability and Physician Liability ... liability,claims in the U.S. health care industry, is published by Aon ...
... One recommendation: MRIs, other scans aren,t always helpful , TUESDAY, ... order MRIs, CT scans and other diagnostic tests for patients ... released by the American College of Physicians and the American ... Oct. 2 issue of the journal Annals of Internal ...
... effects impacting cognition don,t end with the last dose ... cognitive impairment experienced by 14 to 45 percent of ... personal and professional lives. Patients report that the lack ... and the inability to organize or multi-task have led ...
... Holding, Inc. (OTCBB: MITD - News), has signed an ... stop the spread of infectious diseases. Dr. Thomas ... Director of the Biodefense and Infectious Disease Laboratory and ... of Public Health, Georgia Southern University, will oversee the ...
Cached Medicine News:Health News:Mylan Announces Appointment of John Montgomery as President, Asia Pacific 2Health News:Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa 2Health News:Aon Corporation Study Finds Hospital Claims at New Lows 2Health News:Aon Corporation Study Finds Hospital Claims at New Lows 3Health News:Aon Corporation Study Finds Hospital Claims at New Lows 4Health News:Aon Corporation Study Finds Hospital Claims at New Lows 5Health News:Experts Issue Guidelines on Treating Low Back Pain 2Health News:Cognitive deficits lead to 'loss of self' among cancer patients 2
2.0mm Rounded Tip, 12mm From Tip to Bend Gently Curved, 15mm Shaft; In Titanium...
Angled 40 Degrees, 0.6x0.8 Elliptical Tip; in Titanium...
0.5X2.0mm Tip, Oval Shape; in Titanium....
30 Degree Angle Shaft with 1.0mm 90 Degree Angle Tip; in stainless steel....
Medicine Products: